Bruker Corp (BRKR)
59.35
+0.06
(+0.10%)
USD |
NASDAQ |
Nov 04, 16:00
58.00
-1.35
(-2.27%)
After-Hours: 20:00
Bruker Shareholders Equity (Quarterly): 1.789B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.789B |
March 31, 2024 | 1.415B |
December 31, 2023 | 1.377B |
September 30, 2023 | 1.209B |
June 30, 2023 | 1.231B |
March 31, 2023 | 1.180B |
December 31, 2022 | 1.114B |
September 30, 2022 | 937.00M |
June 30, 2022 | 970.50M |
March 31, 2022 | 1.017B |
December 31, 2021 | 1.070B |
September 30, 2021 | 1.076B |
June 30, 2021 | 1.002B |
March 31, 2021 | 967.70M |
December 31, 2020 | 961.20M |
September 30, 2020 | 952.10M |
June 30, 2020 | 897.40M |
March 31, 2020 | 915.60M |
December 31, 2019 | 906.80M |
September 30, 2019 | 845.20M |
June 30, 2019 | 860.80M |
March 31, 2019 | 913.20M |
December 31, 2018 | 896.60M |
September 30, 2018 | 816.90M |
June 30, 2018 | 776.60M |
Date | Value |
---|---|
March 31, 2018 | 781.50M |
December 31, 2017 | 725.40M |
September 30, 2017 | 731.80M |
June 30, 2017 | 755.70M |
March 31, 2017 | 724.70M |
December 31, 2016 | 686.40M |
September 30, 2016 | 693.90M |
June 30, 2016 | 663.30M |
March 31, 2016 | 702.10M |
December 31, 2015 | 726.10M |
September 30, 2015 | 760.30M |
June 30, 2015 | 760.90M |
March 31, 2015 | 715.80M |
December 31, 2014 | 765.90M |
September 30, 2014 | 807.50M |
June 30, 2014 | 880.30M |
March 31, 2014 | 862.60M |
December 31, 2013 | 846.10M |
September 30, 2013 | 777.10M |
June 30, 2013 | 718.90M |
March 31, 2013 | 689.20M |
December 31, 2012 | 706.60M |
September 30, 2012 | 692.70M |
June 30, 2012 | 638.70M |
March 31, 2012 | 658.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
897.40M
Minimum
Jun 2020
1.789B
Maximum
Jun 2024
1.105B
Average
1.017B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Bio-Rad Laboratories Inc | 7.488B |
Azenta Inc | 1.990B |
Harvard Bioscience Inc | 67.25M |
Bionano Genomics Inc | 80.34M |
Akoya Biosciences Inc | 22.25M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.903B |
Total Liabilities (Quarterly) | 4.078B |
Debt to Equity Ratio | 1.206 |
Current Ratio | 1.650 |
Net Debt Paydown Yield | -1.92% |